The Science of The Total Environment, Год журнала: 2024, Номер 958, С. 177980 - 177980
Опубликована: Дек. 9, 2024
Язык: Английский
The Science of The Total Environment, Год журнала: 2024, Номер 958, С. 177980 - 177980
Опубликована: Дек. 9, 2024
Язык: Английский
International Journal of Genomics, Год журнала: 2025, Номер 2025(1)
Опубликована: Янв. 1, 2025
Background: Triple‐negative breast cancer (TNBC) is an aggressive subtype with high malignancy, rapid progression, and a poor 5‐year survival rate of ~77%. Due to the lack targeted therapies, treatment options are limited, highlighting urgent need for novel therapeutic strategies. Myoepithelial cells (MECs) in tumor microenvironment may significantly influence TNBC development progression. Methods: This study used single‐cell RNA sequencing compare MEC gene expression normal versus tissues. TNBC‐associated MECs showed increased proliferation‐ immune‐related genes (e.g., FDCSP, KRT14, KRT17) decreased inflammatory extracellular matrix‐related CXCL8, SRGN, DCN). Copy number variation pseudotime analyses revealed genomic alterations phenotypic dynamics MECs. A CoxBoost‐based prognostic model was developed validated across 20 cohorts, integrating immune profiling, pathway enrichment, drug sensitivity analyses. Mendelian randomization identified TPD52 as risk–associated gene. siRNA knockdown performed cell lines evaluate its effects on proliferation migration. Results: displayed significant changes integrity, impacting responses invasion. The effectively predicted 1‐, 3‐, outcomes, stratifying high‐risk patients enriched cycle DNA replication pathways, reduced checkpoint expression, chemotherapy resistance. tumor‐promoting gene, suppressed Conclusion: highlights MECs’ role provides CoxBoost personalized treatment, identifies potential target intervention.
Язык: Английский
Процитировано
0The Science of The Total Environment, Год журнала: 2024, Номер 958, С. 177980 - 177980
Опубликована: Дек. 9, 2024
Язык: Английский
Процитировано
2